E), CRP (
F) and serum PARC/CCL18 level, respectively. The line represents the regression line of correlation analysis, Pearson correlation coefficients of r-values and p-values were shown at the top right of the picture.
Abbreviations: PARC, pulmonary and activation-regulated chemokine; WBC, white blood cells; Hb, hemoglobin; Plt, blood platelet; Neut, neutrophil granulocyte; Eos, eosinophilic granulocyte; CRP, C-reactive protein.
Serum PARC/CCL18 and Lung Function
Ninety-eight recruited patients were divided into emphysema group and non-emphysema group according to lung CT results. As Figure 5 shows, PARC/CCL18 levels were higher in the emphysema patients than non-emphysema patients in COPD (184.4 vs 117.0 ng/mL, p=0.048). Consistently, PARC/CCL18 levels were significantly associated with TLC (r=0.46, p=0.001) and RV/TLC (r=0.34, p=0.020). Compared with non-emphysema group, there were more males (57 vs 21, p
Tel: +44 (0)20 7933 8780 or [email protected]
Paul McManus / Sam Allen About Belluscura plc ( www.belluscura.com ) Belluscura is a UK medical device company focused on developing oxygen enrichment technology spanning broad industries and therapies. Our innovative oxygen technologies are designed with a global purpose: to create improved health and economic outcomes for the patients, healthcare providers and insurance organisations. Background & history Belluscura was established in the UK in December 2015 with the object of commercialising intellectual property in the medical device space. The Company is currently focused on devices and treatments involving enriched oxygen. The Company has raised approximately $11.7 million since 2018 in a number of fundraising rounds in order to develop and commercialise the Company s product portfolio.
Increasing Demand of Smart Inhalers Market by 2026 | Novartis AG, BoehringerIngelheim International GmbH, Teva Pharmaceutical Industries
iCrowd Newswire
06 May 2021, 18:25 GMT+10
The drugs used in the inhalers include anti-cholinergic, glucocorticoids, insulin, and beta-agonists for the treatment and prevention of respiratory diseases such as asthma and chronic obstructive pulmonary diseases. These inhalers are termed smart inhalers, owing to the sensors attached as a clip on to the inhalers monitoring the right dose per intake and the technique used for inhaling the medication. The data acquired by the sensor is shared with the patient and healthcare professionals to track their inhaler usage
The market growth of smart inhalers can be attributed to factors such as the growing geriatric population globally and the rising number of patients suffering from respiratory diseases. According to the Office of Disease Prevention and Health Promotion, more than 25 million in the U.S. are
Global Portable Oxygen Concentrators Market 2021, Size, Share, Trends and Forecast to 2026
iCrowd Newswire
According to the latest report by IMARC Group
Portable Oxygen Concentrators Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026 , The Global portable oxygen concentrators market size exhibited strong growth during 2015-2020. Looking forward, the market is expected to grow at a CAGR of around 9% during the forecast period (2021-2026).
Portable oxygen concentrators(POCs)are medical devices that separate nitrogen and oxygen from the air and provide pure oxygen to the patient. They come with both a DC adapter to plug into an automobile, boat or motor home and an AC adapter for use in any household outlet. Nowadays, portable oxygen concentrators are available in a variety of sizes, shapes and colors.
Support Services
Behavioral Health practitioners are encouraged to use the toolkit when coordinating care and addressing specific health needs with members. Through the toolkit, practitioners have access to clinical practice guidelines, quality measures, screening and assessment tools, educational resources, conversation starters, integrated health treatment considerations, and much more. At Gateway Health, we are committed to ensuring our members achieve not just physical health, but whole life health, said Regina Vercilla, Vice President, Clinical Strategy and Innovation, Gateway Health. We are proud to support our behavioral health partners with our new toolkit and provide them with the additional resources needed to help our members live a healthier life.